The predictive value of an acute octreotide suppression test in patients with acromegaly
Acromegaly is a rare chronic disorder that is in 95% of cases caused by growth hormone (GH) secreting pituitary tumors. Endonasal transphenoidal surgery is usually considered the first line of treatment, followed by medical therapy for residual disease. The long-acting somatostatin (SA) analogues ha...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
VBZ
2015-12-01
|
| Series: | Endocrine Oncology and Metabolism |
| Subjects: | |
| Online Access: | http://eom.hdeo.eu/wp-content/uploads/2017/02/vol1-iss1-4Strinovic.pdf |